Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Mitsubishi Tanabe Pharma Corp    4508   JP3469000008

MITSUBISHI TANABE PHARMA CORP (4508)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures and distributes pharmaceuticals, pet products and medicines

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products.

Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera.

The company operates through Pharmaceuticals segment.

Mitsubishi Tanabe Pharma was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.
Sales per Businesses
20162017Delta
JPY (in Million)%JPY (in Million)%
Pharmaceutical Business431,701100%423,977100% -1.79%
Sales per Regions
20162017Delta
JPY (in Million)%JPY (in Million)%
Japan314,76472.9%320,36975.6% +1.78%
Europe66,96215.5%57,42513.5% -14.24%
North America31,0437.2%27,0396.4% -12.9%
Asia18,5074.3%18,7524.4% +1.32%
Other425.000.1%392.000.1% -7.76%
Managers
NameAgeSinceTitle
Masayuki Mitsuka, PhD642007President, CEO & Representative Director
Eizou Tabaru602014Director, General Manager-Finance & Accounting
Yoshiaki Ishizaki632007Director & Managing Executive Officer
Seiichi Murakami611980Director & Head-External Affairs
Takashi Kobayashi631980Representative Director
Shigehiko Hattori772011Outside Director
Takashi Tanaka62-Director
Shigeki Iwane652016Outside Director
Tsutomu Kamijo64-Outside Director
Tsutomu Anno--Executive Officer & Deputy General Manager-Sales
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 0.001 561,417,916 237,537,695 42.3% 642,309 0.1% 42.3%
Shareholders
NameEquities%
Mitsubishi Chemical Holdings Corp. 316,320,000 56.3%
Nippon Life Insurance Co. 8,446,000 1.50%
BlackRock Fund Advisors 6,686,000 1.19%
The Vanguard Group, Inc. 5,782,957 1.03%
Nomura Asset Management Co., Ltd. 4,978,200 0.89%
Norges Bank Investment Management 4,347,299 0.77%
Nipro Corp. 3,821,000 0.68%
APG Asset Management NV 3,801,124 0.68%
Daiwa Asset Management Co. Ltd. 2,050,500 0.37%
Grantham, Mayo, Van Otterloo & Co. LLC 1,933,900 0.34%
Holdings
NameEquities%Valuation
SUZUKEN CO., LTD. (9987) 1,548,1911.50%66,846,769 USD
Alfresa Holdings Corporation (2784) 2,225,8120.95%49,296,995 USD
Medipal Holdings Corp (7459) 2,125,7320.87%45,813,776 USD
VITAL KSK HOLDINGS INC (3151) 1,455,0002.38%14,311,918 USD
HOKUYAKU TAKEYAMA Holdings,Inc. (3055) 1,176,0004.82%9,756,425 USD
T&D Holdings Inc (8795) 572,5000.087%9,756,408 USD
Mitsubishi Tanabe Pharma Corp (4508) 430,2000.077%8,218,700 USD
TSURUHA HOLDINGS INC. (3391) 40,0000.082%5,767,979 USD
Mizuho Financial Group, Inc. (8411) 1,616,4000.0064%2,939,860 USD
Create SD Holdings Co Ltd (3148) 3,6000.0054%104,616 USD
Company contact information
Mitsubishi Tanabe Pharma Corp.
3-2-10 Dosho-machi
Chuo-Ku
Osaka 541-8505

Phone : +81.6.6205.5085
Fax : +81.6.6205.5262
Web : www.mt-pharma.co.jp
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MITSUBISHI TANABE PHARMA CORP-16.29%10 014
JOHNSON & JOHNSON-11.45%329 663
PFIZER-1.16%208 947
NOVARTIS-6.55%201 263
ROCHE HOLDING LTD.-8.90%194 670
MERCK AND COMPANY3.87%157 248
AMGEN1.38%118 022
ABBOTT LABORATORIES8.83%107 628
BAYER0.35%106 038
GLAXOSMITHKLINE13.18%100 378
SANOFI-7.89%97 539
NOVO NORDISK A/S-8.28%93 148
ASTRAZENECA5.78%92 764
ELI LILLY AND COMPANY-3.11%89 244
BRISTOL-MYERS SQUIBB COMPANY-14.75%85 552
CELGENE CORPORATION-28.43%55 529
ALLERGAN PLC-5.73%52 548
SHIRE7.87%51 768
JIANGSU HENGRUI MEDICINE CO LTD33.05%42 282
TAKEDA PHARMACEUTICAL CO LTD-29.23%33 630
ASTELLAS PHARMA INC13.79%31 267
© 2018 People , Fundamentals and Ownership